SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Haolin Ni who wrote (212)4/11/1998 11:01:00 PM
From: Cereberus  Read Replies (1) | Respond to of 712
 
Do you foresee CORR's price hanging around the low 20 range because of the Merck news?? Or is the FDA recommendation for Integrillin strong enough to drive the stock upwards??

Cereberus



To: Haolin Ni who wrote (212)4/12/1998 2:05:00 AM
From: shortlong2  Read Replies (1) | Respond to of 712
 
"The production and market abilities of MRK, LLY and CNTO are far better than CORR so that CORR will not get big part of the pie."........... Is CORR a little tyke all by itself on a busy street corner trying to get across the street all by itself, or is Schering Plough going to hold it's hand getting it safely to where it wants to go ?? ....You have heard of Schering Plough haven't you ?..Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News